PART II.-PATHOLOGICAL.
作者信息
O'Meara R A
出版信息
Br Med J. 1930 Aug 16;2(3632):243-4. doi: 10.1136/bmj.2.3632.243.
Abstract
摘要
相似文献
1
PART II.-PATHOLOGICAL.第二部分——病理学
Br Med J. 1930 Aug 16;2(3632):243-4. doi: 10.1136/bmj.2.3632.243.
2
Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma.优化辅助奥沙利铂在临床 II 期或 III 期直肠腺癌中的应用。
Oncologist. 2019 Aug;24(8):e671-e676. doi: 10.1634/theoncologist.2018-0333. Epub 2019 Jan 29.
3
[Gene expression of transforming growth factor beta receptor II in the epidermis of pathological scar].[病理性瘢痕表皮中转化生长因子βⅡ型受体的基因表达]
Zhonghua Shao Shang Za Zhi. 2012 Aug;28(4):278-81.
4
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone.仅接受放射治疗的病理分期为I期和II期弥漫性组织细胞淋巴瘤患者的失败模式。
Int J Radiat Oncol Biol Phys. 1989 Oct;17(4):767-71. doi: 10.1016/0360-3016(89)90064-3.
5
6
Differential diagnosis of hyperintense cerebrospinal fluid on fluid-attenuated inversion recovery images of the brain. Part I: pathological conditions.脑液体衰减反转恢复序列图像上脑脊液高信号的鉴别诊断。第一部分：病理情况。
Br J Radiol. 2009 May;82(977):426-34. doi: 10.1259/bjr/70065269.
7
[Clinical and pathological studies on blood vessel invasion of primary lung cancer. Part II. A pathological study on vascular invasion of primary lung cancer (author's transl)].原发性肺癌血管侵犯的临床与病理研究。第二部分。原发性肺癌血管侵犯的病理研究（作者译）
Nihon Kyobu Geka Gakkai Zasshi. 1978 Nov;26(11):1325-37.
8
Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.肿瘤实性成分的体积定量分析与 3DCT 和 FDG-PET 成像在临床ⅠA 期肺腺癌中的预后价值。
Lung Cancer. 2018 Jul;121:91-96. doi: 10.1016/j.lungcan.2018.05.001. Epub 2018 May 4.
9
Lipid peroxidation: Part II. Pathological implications.脂质过氧化作用：第二部分。病理意义。
Chem Phys Lipids. 1987 Nov-Dec;45(2-4):103-364.
本文引用的文献
1
Lipoid Nephrosis.脂性肾病
Am J Pathol. 1929 Nov;5(6):587-622.5.
Zotero 插件